| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Jan 3, 2023 | Jan 5, 2023 | Chemomab Therapeutics Ltd. | Chief Scientific Officer | Sell | 41.3 | -13,800 | -2.37% | ✓ | $69.4K |
| Nov 16, 2022 | Nov 17, 2022 | Chemomab Therapeutics Ltd. | Chief Scientific Officer | Sell | 17.5 | -582,023 | -50.00% | ✗ | $1.2M |